Senators Push For Oral Cancer Coverage Sooner Than 2006
The Senate report also urged CMS to address the "unintended consequences" of current reimbursement policies that don't cover oral anti-cancer therapies under Medicare Part B. Medicare only covers cancer drugs that a physician administers, which bars access to some potent therapies.But cancer providers and oncology societies express puzzlement about this language in the Senate report, because the Medicare Part D prescription drug program that takes effect next year will cover oral medications.
...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: